This 2019 update from the Oregon Drug Use Research & Management board provides recommendations for the use of opioids in treating non-cancer pain. The document summarizes guidelines on opioid prescribing produced by the Veterans Administration, the American Society of Interventional Pain Physicians, and the Oregon Health Authority.
This 2018 guideline from College of Psychiatric and Neurologic Pharmacists offers advice to pharmacists and providers about tapering patients off long term use of benzodiazepines. Patients prescribed both opioids and benzodiazepines are at higher risk of overdose and death.
This clinician’s guide from the California Health Care Foundation aims to provide primary care providers with “everything they need to know” about buprenorphine. It includes background information on buprenorphine’s effectiveness as a treatment for opioid use disorder and the Drug Addiction Treatment Act
This patient education guide offers advice to patients considering tapering their opioid pain medication.